Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,734
Closed -$797K 752
2025
Q2
$797K Buy
8,734
+378
+5% +$33.8K 0.03% 378
2025
Q1
$765K Sell
8,356
-544
-6% -$47.5K 0.03% 375
2024
Q4
$758K Buy
8,900
+6,411
+258% +$563K 0.06% 310
2024
Q3
$218K Buy
+2,489
New +$209K 0.02% 498
2024
Q2
Sell
-2,266
Closed -$205K 511
2024
Q1
$205K Buy
+2,266
New +$207K 0.02% 485
2023
Q3
Sell
-2,990
Closed -$259K 465
2023
Q2
$259K Sell
2,990
-408
-12% -$38.4K 0.03% 396
2023
Q1
$326K Buy
3,398
+636
+23% +$58.8K 0.03% 382
2022
Q4
$251K Buy
2,762
+238
+9% +$20.2K 0.03% 419
2022
Q3
$218K Buy
+2,524
New +$214K 0.03% 442

Other funds holding DOX

Ascent Group's DOX Position: Q3 2025 in Review

Ascent Group sold out of Amdocs (DOX) in Q3 2025, closing a stake of 8,734 shares — an estimated $797K sold.

Ascent Group first reported a position in DOX in Q3 2022 and held it in 9 quarters. The position peaked at $797K in Q2 2025. 526 funds tracked by Wall St. Rank hold DOX as of Q3 2025.

  • Ascent Group reported no remaining Amdocs position as of Q3 2025 after selling out during the quarter.
  • Ascent Group sold 8,734 Amdocs shares in Q3 2025, an estimated $797K.
  • Ascent Group first reported a position in Amdocs in Q3 2022 and held it in 9 quarters.
  • Ascent Group's Amdocs position peaked at $797K in Q2 2025.
  • 526 funds tracked by Wall St. Rank held Amdocs as of Q3 2025.

Based on Ascent Group's 13F filing for Q3 2025, filed 20 Oct 2025.